Skip to main content

6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine

ADVERTISEMENT
Identification
Molecular formula
C6H10N4
CAS number
Not Available
IUPAC name
6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine
State
State

At room temperature, 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine is generally found in a liquid state.

Melting point (Celsius)
-32.00
Melting point (Kelvin)
241.15
Boiling point (Celsius)
245.00
Boiling point (Kelvin)
518.15
General information
Molecular weight
124.15g/mol
Molar mass
124.1480g/mol
Density
1.2043g/cm3
Appearence

6,7,8,9-Tetrahydro-5H-tetrazolo[1,5-a]azepine typically appears as a colorless to pale yellow liquid. It is often found in its pure form in laboratory settings.

Comment on solubility

Solubility of 6,7,8,9-Tetrahydro-5H-tetrazolo[1,5-a]azepine (C6H10N4)

The solubility of 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine plays a crucial role in its applications and behavior in various environments. Understanding its solubility characteristics can provide insights into its potential usability in pharmaceuticals and other chemical processes.

Key Factors Affecting Solubility

Several factors influence the solubility of this compound, including:

  • Polarity: The presence of nitrogen atoms can contribute to polar interactions, affecting solubility in polar solvents.
  • Hydrogen Bonding: The ability to form hydrogen bonds can increase solubility in water.
  • Temperature: Solubility often increases with temperature, which is essential when considering it in various applications.

Solubility in Common Solvents

While specific solubility data for this compound may not be abundantly available, it can be surmised that:

  • High solubility: Possible in polar solvents such as water or methanol due to its structure.
  • Limited solubility: In non-polar solvents like hexane due to its overall polar characteristics.

Overall, it is essential to keep in mind that the solubility of 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine is determined by a combination of molecular structure, external conditions, and solvent characteristics. Understanding these aspects can guide researchers in utilizing this compound more effectively in various applications.

Interesting facts

Interesting Facts about 6,7,8,9-Tetrahydro-5H-tetrazolo[1,5-a]azepine

6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine is a fascinating compound that belongs to the class of heterocyclic compounds. Here are some intriguing insights about this compound:

  • Unique Structure: The compound features a unique bicyclic structure consisting of both azepine and tetrazole rings. This structural combination gives rise to interesting chemical properties and potential biological activities.
  • Biological Significance: Compounds with tetrazole moieties are often explored for their pharmacological properties. The presence of the tetrazole group can enhance the activity or bioavailability of drugs, making them important in medicinal chemistry.
  • Potential Applications: Research into this compound may reveal applications in fields such as:
    • Pharmaceuticals, particularly as potential candidates for antipsychotic or anxiolytic medications.
    • Materials science, where variations of these compounds can be utilized in developing new materials with specific functionalities.
  • Synthesis Challenges: The synthesis of 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine can be complicated. Chemists often employ multi-step synthetic routes combining various reagents and conditions to achieve the desired compound.
  • Research Directions: Ongoing research may focus on:
    • Understanding its reactivity and stability.
    • Evaluating its interactions with biological targets.
    • Exploring its derivative compounds for enhanced properties.

As with many compounds in organic chemistry, the unique characteristics of 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine open doors to numerous possibilities in research and industry. The exploration of its potential can lead to significant advancements in various scientific fields.

Synonyms
Pentetrazol
PENTYLENETETRAZOLE
Pentylenetetrazol
54-95-5
Metrazole
Cardiazol
1,5-Pentamethylenetetrazole
Cardiazole
Cardiol
Corazole
Korazol
Metrazol
Coranormol
Korazole
Leptazol
Leptazole
Cenazol
Corazol
Coryvet
Pentetrazole
Pentazol
Pentamethylenetetrazole
Cardiotonicum
Pentamethazol
Cardifortan
Cardosal
Cardosan
Coratoline
Corvasol
Deumacard
Diovascole
Kardiazol
Phrenazol
Ventrazol
Corasol
Gewazol
6,7,8,9-Tetrahydro-5H-tetrazolo[1,5-a]azepine
Pentamethylenetetrazol
Pentamethazolum
Angiazol
Centrazole
Coranormal
Corsedrol
Deamocard
Nauranzol
Naurazol
Nedcardol
Neocardol
Neurazol
Pemetesan
Penetrasol
Pentacard
Pentazolum
Pentemesan
Pentrazol
Pentrolone
Pentrozol
Petrazole
Phrenazone
Tetracor
Tetrazol
Yetrazol
Corisan
Cortis
Corvis
Opticor
Vasorex
Cerebro-nicin
Novo cora-vinco
Cenalene-M
Metalex-P
Corazole (analeptic)
Delzol-W
Pentamethylene-1,5-tetrazole
Tetrazole, pentamethylene-
TT87
Penetratsol
Pentetrazolum
Stellacardiol
Stillcardiol
Angioton
Lepazol
Penetiazol
Pentacor
Petazol
Petezol
alpha,beta-Cyclopentamethylenetetrazole
PTZ
6,7,8,9-Tetrahydro-5-azepotetrazole
Tetrazole, (1,5-pentanediyl)-
Pentametilentetrazolo
Pentetrazol [INN]
6,7,8,9-Tetrahydro-5H-tetrazoloazepine
5H-Tetrazolo[1,5-a]azepine, 6,7,8,9-tetrahydro-
Cardiozol
Su-Zol
Pentamethylenetetrazal
NSC-5729
NSC-66489
1,2,3,3a-Tetrazacyclohepta-8a,2-cyclopentadiene
5H-Tetrazolo(1,5-a)azepine, 6,7,8,9-tetrahydro-
.alpha.,.beta.-Cyclopentamethylenetetrazole
WM5Z385K7T
DTXSID7041091
CHEBI:34910
NSC5729
6,7,8,9-Tetrahydro-5H-tetrazolo(1,5-a)azepine
NSC66489
Pentetrazol (INN)
7,8,9,10-Tetrazabicyclo(5.3.0)-8,10-decadiene
7,8,9,10-Tetrazabicyclo[5.3.0]-8,10-decadiene
MFCD00005939
CAS-54-95-5
NCGC00015827-06
Pentetratsol
Corazolum
Pentrazole
Tetrazole,5-pentanediyl)-
WLN: T57 ANNNN&TJ
PMT
Pentetrazolo [DCIT]
Pentetrazolo
6,8,9-Tetrahydro-5-azepotetrazole
6,8,9-Tetrahydro-5H-tetrazoloazepine
Pentetrazolum [INN-Latin]
5H-Tetrazoloazepine,7,8,9-tetrahydro-
5H-Tetrazolo[1, 6,7,8,9-tetrahydro-
Pentametilentetrazolo [Italian]
1,3,3a-Tetrazacyclohepta-8a,2-cyclopentadiene
Pentylenetetrazol [NF]
7,9,10-Tetrazabicyclo[5.3.0]-8,10-decadiene
SR-01000076073
NSC 5729
EINECS 200-219-3
NSC 66489
BRN 0135492
UNII-WM5Z385K7T
Pentavet
pentylentetrazole
AI3-23994
Cenalene M
Delzol W
Prestwick_382
Pentamethylene tetrazole
Spectrum_000393
SpecPlus_000787
5H-Tetrazoloazepine, 6,7,8,9-tetrahydro-
Prestwick0_000162
Prestwick1_000162
Prestwick2_000162
Prestwick3_000162
Spectrum2_001121
Spectrum3_001408
Spectrum4_000242
Spectrum5_001338
Lopac-P-6500
Biomol-NT_000269
Coryvet [veterinary] (TN)
PENTETRAZOL [MART.]
Lopac0_000940
SCHEMBL22674
1, 5-Pentamethylenetetrazole
1,5-pentamethylene tetrazole
BSPBio_000023
BSPBio_003056
KBioGR_000644
KBioSS_000873
PENTETRAZOL [WHO-DD]
4-26-00-01713 (Beilstein Handbook Reference)
DivK1c_006883
SPECTRUM2300347
SPBio_000981
SPBio_001944
PENTYLENETETRAZOLE [MI]
BPBio1_000027
BPBio1_000860
CHEMBL116943
DTXCID5021091
KBio1_001827
KBio2_000873
KBio2_003441
KBio2_006009
KBio3_002276
PENTYLENETETRAZOL [VANDF]
HMS1568B05
HMS2093P18
HMS2095B05
HMS3262L22
HMS3269N13
HMS3414P17
HMS3678P15
HMS3712B05
HMS3885P08
Pharmakon1600-02300347
HY-B1242
Tox21_110234
Tox21_500940
CCG-40268
HB0481
NSC759592
s4587
STL356056
AKOS005207166
CS-4890
DB13415
FP26833
LP00940
NSC-759592
SB17494
SDCCGSBI-0050914.P004
NCGC00015827-01
NCGC00015827-02
NCGC00015827-03
NCGC00015827-04
NCGC00015827-05
NCGC00015827-07
NCGC00015827-08
NCGC00015827-09
NCGC00015827-17
NCGC00094246-01
NCGC00094246-02
NCGC00094246-03
NCGC00094246-04
NCGC00094246-05
NCGC00261625-01
AS-47604
6,7,8, 9-Tetrahydro-5H-tetrazoloazepine
SBI-0050914.P003
AB00052439
EU-0100940
NS00003740
P0046
5H-Tetrazoloazepine, 6,7,8, 9-tetrahydro-
D07409
F14615
P 6500
AB00052439_04
Q412391
1,2,3, 3a-Tetrazacyclohepta-8a,2-cyclopentadiene
6,7,8,9-Tetrahydro-5H-tetraazolo[1,5-a]azepine
6,7,8,9-Tetrahydro-5H-tetrazolo[1,5 -a]azepine
SR-01000076073-1
SR-01000076073-3
SR-01000076073-5
6,7,8,9-Tetrahydro-5H-tetraazolo[1,5-a]azepine #
7,8,9,10-Tetrazabicyclo[5.3.0]deca-8,10-diene
BRD-K57718010-001-01-0
BRD-K57718010-001-08-5
BRD-K57718010-001-10-1
BRD-K57718010-001-11-9
BRD-K57718010-001-12-7
{5H-Tetrazolo[1,5-a]azepine,} 6,7,8,9-tetrahydro-
7,8,9, {10-Tetrazabicyclo[5.3.0]-8,10-decadiene}
20192-24-9